Lancet neurology
The most recent articles from:
Lancet Neurol
-
Clinical Trial
Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
The European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) is a prospective international registry investigating the natural history of Friedreich's ataxia. We used data from EFACTS to assess disease progression and the predictive value of disease-related factors on progression, and estimated sample sizes for interventional randomised clinical trials. ⋯ European Commission.
-
Biography Historical Article
A modern perspective on Pope Innocent X's tremor.
-
Biography Historical Article
Brian Weinshenker: poking holes in time and space.
-
Comment Letter
Omega-3 fatty acids and SUDEP prevention - Authors' reply.